Delcath Systems to Host First Quarter 2026 Earnings Call
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma [Yahoo! Finance]
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting
Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030 [Yahoo! Finance]